Breast Cancer Therapies in Development
- 1 September 1997
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 54 (3) , 385-413
- https://doi.org/10.2165/00003495-199754030-00003
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Drug Resistance-Associated Marker Lrp for Prediction of Response to Chemotherapy and Prognoses in Advanced Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Droloxifene, a new antiestrogen: Its role in metastatic breast cancerBreast Cancer Research and Treatment, 1994
- Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancerEuropean Journal Of Cancer, 1994
- FormestaneDrugs, 1993
- Overview of new treatments for breast cancerBreast Cancer Research and Treatment, 1992
- Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin AEuropean Journal of Cancer and Clinical Oncology, 1991
- 5-HT3 Receptor AntagonistsDrugs, 1991
- Distribution of fenretinide in the mammary gland of breast cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1991
- Tolerability of the synthetic retinoid fenretinide® (HPR)European Journal of Cancer and Clinical Oncology, 1989
- Antagonism of estrogen action with a new benzothiophene derived antiestrogenLife Sciences, 1983